Table 5.
Distribution of MDR among uropathogens isolated from the study group
| Isolated organisms | Number of drugs affected by the isolate | Total | |||||
|---|---|---|---|---|---|---|---|
| R0 | R1 | R2 | R3 | R4 | R5 | ||
| E. coli (n = 30) | 2 (6.67%) | 1 (3.33%) | 8 (26.67%) | 10 (33.33%) | 2 (6.67%) | 7 (23.33%) | 30 |
| K. pneumoniae (n = 2) | 0 (0.0%) | 0 (0.0%) | 1 (50%) | 1 (50%) | 0 (0.0%) | 0 (0.0%) | 2 |
| E. cloacae (n = 1) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (100%) | 1 |
| S. aureus (n = 11) | 0 (0.0%) | 3 (27.27%) | 3 (27.27%) | 2 (18.18%) | 1 (9.09%) | 2 (18.18%) | 11 |
| CoNS (n = 17) | 0 (0.0%) | 2 (11.76%) | 2 (11.76%) | 3 (17.65%) | 1 (5.88%) | 9 (52.94%) | 17 |
| Total (61) | 2 (3.28%) | 6 (9.84%) | 14 (22.95%) | 16 (26.23%) | 4 (6.56%) | 19 (31.15%) | 61 |
R0, resistant to none (sensitive to all); R1, resistant to one; R2, resistant to two; R3, resistant to three; R4, resistant to four and R5, resistant to five and more antibiotics tested